Caption Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-544,900
Closed -$6.47M 1505
2024
Q4
$6.47M Buy
544,900
+394,900
+263% +$6.73M 0.06% 295
2024
Q3
$4.15M Sell
150,000
-547,300
-78% -$13.7M 0.07% 344
2024
Q2
$16.6M Buy
697,300
+107,100
+18% +$2.51M 0.26% 82
2024
Q1
$10.4M Buy
590,200
+30,200
+5% +$445K 0.16% 155
2023
Q4
$8.84M Hold
560,000
0.12% 198
2023
Q3
$4.82M Sell
560,000
-240,000
-30% -$1.7M 0.07% 327
2023
Q2
$6.31M Buy
800,000
+705,000
+742% +$4.91M 0.11% 233
2023
Q1
$708K Hold
95,000
0.01% 709
2022
Q4
$1.12M Buy
+95,000
New +$1.09M 0.02% 710
2021
Q4
Sell
-115,000
Closed -$5.29M 1581
2021
Q3
$5.29M Hold
115,000
0.06% 438
2021
Q2
$3.44M Buy
+115,000
New +$2.35M 0.04% 491

Other funds holding ASPN

Caption Management's ASPN Position: Q1 2026 in Review

Caption Management sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 36,100 shares — an estimated $102K sold.

Caption Management first reported a position in ASPN in Q2 2021 and held it in 14 quarters. The position peaked at $4.76M in Q2 2023. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Caption Management reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 36,100 Aspen Aerogels shares in Q1 2026, an estimated $102K.
  • Caption Management first reported a position in Aspen Aerogels in Q2 2021 and held it in 14 quarters.
  • Caption Management's Aspen Aerogels position peaked at $4.76M in Q2 2023.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.